HY-104021-100mg
|
MedChemexpress LLC
|
GSK840 [CAS 2361146-30-5]
|
|
COVID-19-immunoregulation
|
|
HY-104021-5mg
|
MedChemexpress LLC
|
GSK840 [CAS 2361146-30-5]
|
|
COVID-19-immunoregulation
|
|
HY-104021-50mg
|
MedChemexpress LLC
|
GSK840 [CAS 2361146-30-5]
|
|
COVID-19-immunoregulation
|
|
HY-10405-10mg
|
MedChemexpress LLC
|
Pamapimod [CAS 449811-01-2]
|
|
Cancer-Kinase/protease
|
|
HY-10405-25mg
|
MedChemexpress LLC
|
Pamapimod [CAS 449811-01-2]
|
|
Cancer-Kinase/protease
|
|
HY-10405-5mg
|
MedChemexpress LLC
|
Pamapimod [CAS 449811-01-2]
|
|
Cancer-Kinase/protease
|
|
HY-10405-50mg
|
MedChemexpress LLC
|
Pamapimod [CAS 449811-01-2]
|
|
Cancer-Kinase/protease
|
|
HY-108444-1mg
|
MedChemexpress LLC
|
(Z)-FeCP-oxindole [CAS 1137967-28-2]
|
|
Cancer-Kinase/protease
|
|
HY-108444-10mg
|
MedChemexpress LLC
|
(Z)-FeCP-oxindole [CAS 1137967-28-2]
|
|
Cancer-Kinase/protease
|
|
HY-108444-100mg
|
MedChemexpress LLC
|
(Z)-FeCP-oxindole [CAS 1137967-28-2]
|
|
Cancer-Kinase/protease
|
|
HY-108444-25mg
|
MedChemexpress LLC
|
(Z)-FeCP-oxindole [CAS 1137967-28-2]
|
|
Cancer-Kinase/protease
|
|
HY-108444-5mg
|
MedChemexpress LLC
|
(Z)-FeCP-oxindole [CAS 1137967-28-2]
|
|
Cancer-Kinase/protease
|
|
HY-108444-50mg
|
MedChemexpress LLC
|
(Z)-FeCP-oxindole [CAS 1137967-28-2]
|
|
Cancer-Kinase/protease
|
|
HY-108444A-1mg
|
MedChemexpress LLC
|
(E)-FeCP-oxindole [CAS 884338-18-5]
|
|
|
|
HY-108485-1mg
|
MedChemexpress LLC
|
Damnacanthal [CAS 477-84-9]
|
|
Neuroscience-Neurodegeneration
|
|
HY-108485-5mg
|
MedChemexpress LLC
|
Damnacanthal [CAS 477-84-9]
|
|
Neuroscience-Neurodegeneration
|
|
HY-109091-10mg
|
MedChemexpress LLC
|
Lanraplenib [CAS 1800046-95-0]
|
|
COVID-19-immunoregulation
|
|
HY-109091-100mg
|
MedChemexpress LLC
|
Lanraplenib [CAS 1800046-95-0]
|
|
COVID-19-immunoregulation
|
|
HY-109091-5mg
|
MedChemexpress LLC
|
Lanraplenib [CAS 1800046-95-0]
|
|
COVID-19-immunoregulation
|
|
HY-109091-50mg
|
MedChemexpress LLC
|
Lanraplenib [CAS 1800046-95-0]
|
|
COVID-19-immunoregulation
|
|
HY-109091B-10mg
|
MedChemexpress LLC
|
Lanraplenib (succinate) [CAS 1800047-00-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-109091B-100mg
|
MedChemexpress LLC
|
Lanraplenib (succinate) [CAS 1800047-00-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-109091B-5mg
|
MedChemexpress LLC
|
Lanraplenib (succinate) [CAS 1800047-00-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-109091B-50mg
|
MedChemexpress LLC
|
Lanraplenib (succinate) [CAS 1800047-00-0]
|
|
Neuroscience-Neuromodulation
|
|
HY-109968-1mg
|
MedChemexpress LLC
|
Irdabisant [CAS 1005402-19-6]
|
|
Neuroscience-Neuromodulation
|
|